Skip to main content
. 2017 Dec 27;2(1):1–9. doi: 10.1182/bloodadvances.2017013334

Table 3.

Results from multivariable Cox regression analysis in patients treated with PAD

All patients High-risk patients
PFS OS PFS OS
HR (95% CI) P HR (95% CI) P HR (95% CI) P HR (95% CI) P
Subclone 1.28 (0.85-1.92) .233 2.07 (1.15-3.73) .016 2.11 (1.01-4.43) .048 3.24 (1.19-8.83) .022
ISS II 1.20 (0.77-1.88) .414 1.85 (1.01-3.38) .046 0.60 (0.26-1.37) .227 0.93 (0.34-2.55) .890
ISS III 1.41 (0.86-2.32) .176 1.63 (0.82-3.26) .167 0.78 (0.29-2.09) .625 0.76 (0.23-2.53) .654
Age 1.01 (0.98-1.03) .653 1.04 (1.00-1.08) .034 0.99 (0.94-1.03) .553 1.00 (0.94-1.06) .963
High LDH 2.28 (1.38-3.76) .001 3.29 (1.79-6.06) .0001 2.19 (0.73-6.55) .160 4.68 (1.52-14.4) .007
HR main 1.61 (1.06-2.46) .025 2.06 (1.23-3.46) .006

Bold type indicates significant P values.